On 14 August 2017
Mesco Pharmaceuticals will hold a meeting of the Board of Directors of the Company on 14 August 2017, to approve Unaudited Financial Results pursuant to Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulation 2015 for the quarter ended 30th June, 2017Powered by Capital Market - Live News
Disclaimer: No Business Standard Journalist was involved in creation of this content
